Angela T Anderson

About

Angela T Anderson, MD, is an Assistant Professor of Clinical Psychiatry and an Attending Physician at the Children's Hospital of Philadelphia. She holds a B.S. in Psychology and Biomedical Engineering Systems from Tufts University and earned her M.D. from Albert Einstein College of Medicine. Her professional work includes producing educational content on mental health topics such as anxiety and depression for teens and young adults, serving as an executive producer for related YouTube videos. Her research and professional contributions also encompass promoting diversity, equity, and inclusion through anti-racism initiatives, including organizing book clubs and supporting colleagues' mental health during racial pandemics. She has been involved in various scholarly activities, including presentations at the Society of Pediatric Psychology Annual Conference and media interviews on mental health topics.

Research topics

• Medicine
• Internal medicine
• Urology
• Biology
• Endocrinology

Selected publications

• Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

  Journal of the American Society of Nephrology · 2020 · 141 citations

  BACKGROUND: Although diabetic kidney disease is the leading cause of ESKD in the United States, identifying those patients who progress to ESKD is difficult. Efforts are under way to determine if plasma biomarkers can help identify these high-risk individuals. METHODS: at baseline, participants were randomly selected for the subcohort; cases were those patients who developed progressive diabetic kidney disease (ESKD or 40% eGFR decline). Using a multiplex system, we assayed plasma biomarkers rel…

  DOI

• Matrix Metalloproteinase-2 and CKD Progression: The Chronic Renal Insufficiency Cohort (CRIC) Study

  Kidney Medicine · 2024-06-07 · 7 citations

  articleOpen accessCorresponding

  Rationale & Objective: Matrix metalloproteinase 2 (MMP-2) plays an important role in the development of fibrosis, the final common pathway of chronic kidney disease (CKD). This study aimed to assess the relationship between repeated measures of MMP-2 and CKD progression in a large, diverse prospective cohort. Study Design: In a prospective cohort of Chronic Renal Insufficiency Cohort (CRIC) participants (N = 3,827), MMP-2 was measured at baseline. In a case-cohort design, MMP-2 was additionally…

  PublisherOA PDFDOI

• Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation

  BMC Nephrology · 2024-05-30 · 5 citations

  articleOpen access

  BACKGROUND: Protein carbamylation, a post-translational protein modification primarily driven by urea, independently associates with adverse clinical outcomes in patients with CKD. Biomarkers used to quantify carbamylation burden have mainly included carbamylated albumin (C-Alb) and homocitrulline (HCit, carbamylated lysine). In this study, we aimed to compare the prognostic utility of these two markers in order to facilitate comparisons of existing studies employing either marker alone, and to…

  PublisherOA PDFDOI

• Pulse Pressure and Cardiovascular and Kidney Outcomes by Age in the Chronic Renal Insufficiency Cohort (CRIC)

  American Journal of Hypertension · 2024-10-22 · 5 citations

  articleOpen access

  BACKGROUND: Wide pulse pressure (PP) is associated with cardiovascular events and the progression of chronic kidney disease (CKD) to kidney failure. PP naturally widens with age, but it is unclear whether the risks associated with greater PP are the same across all ages. METHODS: We used Cox proportional hazards models to investigate the association of PP with (i) atherosclerotic cardiovascular disease (ASCVD) events or death and (ii) a 50% reduction in estimated glomerular filtration rate or ki…

  PublisherOA PDFDOI

• Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease

  JACC Advances · 2025-08-20 · 4 citations

  articleOpen access

  BACKGROUND: Chronic kidney disease (CKD) is a risk-enhancing factor for cardiovascular disease (CVD) and is associated with higher lipoprotein(a) (Lp[a]) levels. While aspirin may reduce Lp(a)-related prothrombotic risk, the role of primary prevention aspirin for persons with CKD and elevated Lp(a) is unclear. OBJECTIVES: The aim of the study was to assess the association of aspirin use with cardiovascular, renal, and bleeding outcomes stratified by Lp(a) level among individuals with CKD without…

  PublisherDOI

Recent grants

• The Gut Microbiome and The Metabolome in Chronic Kidney Disease

  NIH · $2.8M · 2024–2024

• NIH Grant K01DK092353

  NIH · $650k · 2016

• Continuation of the Chronic Renal Insufficiency Cohort (CRIC)

  NIH · $20.5M · 2001–2028

Frequent coauthors

• Harold I. Feldman

  University of Illinois Chicago

  524 shared

• Raymond R. Townsend

  501 shared

• Jiang He

  Central South University

  497 shared

• Radhakrishna R. Kallem

  University of Pennsylvania

  406 shared

• Jackson T. Wright

  Case Western Reserve University

  406 shared

• John W. Kusek

  University of Pennsylvania

  388 shared

• Mahboob Rahman

  377 shared

• Dawei Xie

  361 shared

Similar researchers at University of Pennsylvania

• John Q. Trojanowskih-296
• Craig B. Thompsonh-277
• Daniel J Raderh-236